MedTrace Logo

Irisin And Diabetic Nephropathy

NCT05144672 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 90

Last updated 2021-12-03

No results posted yet for this study

Summary

Diabetes mellitus (DM) is a complex, multifactorial, chronic metabolic and endocrine disorder. It has become a threat to global health. It has two types. It is estimated that the number of people with type II will reach 700 million by 2045.

Conditions

  • Irisin

Interventions

DIAGNOSTIC_TEST

Laboratory tests

Fasting blood glucose (FBG), postprandial blood glucose, total cholesterol (CHO), triglycerides (TG), high-density lipoprotein cholesterol and low-density lipoprotein cholesterol (LDL-C), urea, creatinine, and uric acid by point colorimetric assay. Serum irisin.

OTHER

Anthropometric measurements

Height, weight, waist circumference, and hip circumference were taken as a way of assessing the nutritional status and BMI

PROCEDURE

Electrocardiogram and Fundus examination

Fundus examination by direct ophthalmoscope

OTHER

Estimated glomerular filtration rate (eGFR)

Estimated glomerular filtration rate (eGFR) was calculated by EPI equation.

OTHER

Brachial index

The ankle-brachial index test compares the blood pressure measured at your ankle with the blood pressure measured at your arm

DIAGNOSTIC_TEST

Laboratory tests

Glycosylated haemoglobin. ACR,urinary albumin (mg) and creatinine (g).

RADIATION

Abdominal ultrasound.

It will be performed for patients only.

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-01
Primary Completion
2023-04-30
Completion
2023-06-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05144672 on ClinicalTrials.gov